Ketamine in The Treatment of ALS
Preclinical research has shown that the administration of ketamine preserves muscle function in advancing ALS and increases life expectancy when given in the early stages of muscle decline.
Another preclincial research success story. Will further clinical trials, be timely and backup the original claims or is this just more dashed hopes?
Log in to reply.